CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Open-market buy CEO bought 530,767 shares at an average $0.03 ($18,126)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $0.04 ($800)
- 4 Open-market buy Co-President & COO bought 115,200 shares at an average $0.13 ($14,694)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy COO bought 121,000 shares at an average $0.13 ($15,285)
- 4 Open-market sale Director sold 32,500 shares at $0.05 ($1,625)
- 3/A Insider 3/A
- 4 Open-market buy Director bought 139,200 shares at an average $0.22 ($30,916)
- 4 Other acquisition Director acquired 3,760,983 shares (other)
- 4 Open-market buy COO bought 15,609 shares at an average $0.13 ($2,023)
- 4 Open-market buy COO bought 29,450 shares at an average $0.29 ($8,533)
- 4 Derivatives Options or other derivatives
Page 1 of 25 · 488 filings